Immunotherapy with Long-Lived Anti-CD20 x Anti-CD3 Bispecific Antibodies Stimulates Potent T Cell-Mediated Killing of Human B Cell Lines and of Circulating and Lymphoid B Cells in Monkeys: A Potential Therapy for B Cell Lymphomas and Leukemias

被引：0
|
作者：
Chu, Seung Y. [1 ]
Lee, Sung-Hyung [1 ]
Rashid, Rumana [1 ]
Chen, Hsing [1 ]
Chan, Emily W. [1 ]
Phung, Sheryl [1 ]
Pong, Erik [1 ]
Endo, Nancy A. [1 ]
Miranda, Yvonne [1 ]
Bonzon, Christine [1 ]
Leung, Irene W. L. [1 ]
Muchhal, Umesh S. [1 ]
Moore, Gregory L. [1 ]
Bernett, Matthew J. [1 ]
Szymkowski, David E. [1 ]
Desjarlais, John R. [1 ]
机构：
[1] Xencor Inc, Monrovia, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action
    Qu, Zhengxing
    Goldenberg, David M.
    Cardillo, Thomas M.
    Shi, Victoria
    Hansen, Hans J.
    Chang, Chien-Hsing
    BLOOD, 2008, 111 (04) : 2211 - 2219
  • [42] Anti-CD3ε induces splenic B220lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization
    Todo, Tsuyoshi
    Wu, Gordon
    Chai, Ning-ning
    He, Yao
    Martins, Gislaine
    Gupta, Ankur
    Fair, Jeffrey
    Liu, Nai-you
    Jordan, Stanley
    Klein, Andrew
    INTERNATIONAL IMMUNOLOGY, 2012, 24 (08) : 529 - 538
  • [43] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [44] Anti-idiotype x anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma
    Avin, E
    Haimovich, J
    Hollander, N
    JOURNAL OF IMMUNOLOGY, 2004, 173 (07): : 4736 - 4743
  • [45] INDUCTION OF T-CELL-DEPENDENT B-CELL DIFFERENTIATION BY ANTI-CD3 MONOCLONAL-ANTIBODIES
    STOHL, W
    POSNETT, DN
    CHIORAZZI, N
    JOURNAL OF IMMUNOLOGY, 1987, 138 (06): : 1667 - 1673
  • [46] Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
    Nirav N. Shah
    Bryon D. Johnson
    Dina Schneider
    Fenlu Zhu
    Aniko Szabo
    Carolyn A. Keever-Taylor
    Winfried Krueger
    Andrew A. Worden
    Michael J. Kadan
    Sharon Yim
    Ashley Cunningham
    Mehdi Hamadani
    Timothy S. Fenske
    Boro Dropulić
    Rimas Orentas
    Parameswaran Hari
    Nature Medicine, 2020, 26 : 1569 - 1575
  • [47] Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
    Shah, Nirav N.
    Johnson, Bryon D.
    Schneider, Dina
    Zhu, Fenlu
    Szabo, Aniko
    Keever-Taylor, Carolyn A.
    Krueger, Winfried
    Worden, Andrew A.
    Kadan, Michael J.
    Yim, Sharon
    Cunningham, Ashley
    Hamadani, Mehdi
    Fenske, Timothy S.
    Dropulic, Boro
    Orentas, Rimas
    Hari, Parameswaran
    NATURE MEDICINE, 2020, 26 (10) : 1569 - +
  • [48] B and T cell immunity in MS with anti-CD20 therapy: Gene expression and protein profiles
    Fong, C.
    Spencer, J.
    Howlett-Prieto, Q.
    Park, G.
    Feng, X.
    Reder, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 535 - 535
  • [49] Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Bannerji, Rajat
    Allan, John N.
    Arnason, Jon E.
    Brown, Jennifer R.
    Advani, Ranjana H.
    Barnes, Jeffrey A.
    Ansell, Stephen M.
    O'Brien, Susan M.
    Chavez, Julio
    Duell, Johannes
    David, Kevin A.
    Martin, Peter
    Joyce, Robin M.
    Charnas, Robert
    Ambati, Srikanth R.
    Adriaens, Lieve
    Ufkin, Melanie
    Zhu, Min
    Li, Jingjin
    Gasparini, Peter
    Ibrahim, Anfal
    Jankovic, Vladimir
    Fiaschi, Nathalie
    Aina, Olulanu
    Zhang, Wen
    Deering, Raquel P.
    Hamon, Sara
    Thurston, Gavin
    Murphy, Andrew J.
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Sternberg, David
    Topp, Max S.
    BLOOD, 2019, 134
  • [50] Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies
    Schuster, Friedhelm R.
    Stanglmaier, Michael
    Woessmann, Wilhelm
    Winkler, Beate
    Siepermann, Meinolf
    Meisel, Roland
    Schlegel, Paul G.
    Hess, Juergen
    Lindhofer, Horst
    Borkhardt, Arndt
    Buhmann, Raymund
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 90 - 102
12345